SYNTARA LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.018 AUD | -5.26% |
|
0.00% | -10.00% |
| Apr. 30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
| Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 15.13M | - | |||||
| 723B | ||||||
| 598B | ||||||
| 364B | ||||||
| 331B | ||||||
| 288B |
- Stock Market
- Equities
- SNT Stock
- Charts Syntara Limited
- Sector Chart
